Insightec Raises $150M for Expansion of Exablate Prime Platform

Insightec raises $150M in Equity Funding

Insightec (Linkedin), a leading healthcare company in focused ultrasound technology, recently secured $150M in equity funding. With a focus on treating essential tremor and Parkinson's disease, Insightec's Exablate Prime platform is set to revolutionize neurology and movement disorder treatment.

Funding Amount: $150 million

Industry: Medical Equipment Manufacturing

Employee Count: 201-500

CEO: Maurice R. Ferre M.D. (CEO Linkedin)

What Insightec needs to buy: Insightec is seeking partnerships with research institutions, manufacturers, and marketing and sales support services. Companies specializing in medical device distribution, manufacturing, and digital marketing can collaborate with Insightec to advance their focused ultrasound technology, expand their product line, and reach a wider customer base in the healthcare industry.